Diabetes patients who had percutaneous stenting for ST-segment elevation myocardial infarction appeared to face a greater risk of heart attack and all-cause mortality than those who did not have diabetes, a Scandinavian study found. Future work should focus on "identifying other treatment strategies for improving prognosis including increasing microvascular perfusion within the ischemic myocardium," the researchers said.

Related Summaries